Some of chronic benign recurrent dermatoses are markedly recalcitrant to the ordinary dermatological treatments. The author studied the therapeutic effect of beta ray on those of 30 patients including 6 cases of psoriasis, 3 of lichen simplex chronicus, 9 of nummular eczema, 8 of pustulosis palmaris et plantaris, and 4 of chronic eczema of the finger. All of the above were promptly recurred with ordinary treatments. Strontium 90 applicator was used as the source of beta ray and the total irradiation doses to each sites were ranged from 600 to 1500 rads in divided doses(usually weekly) over 2 to 3 weeks. The results were as follows, 1. In psoriasis patients with papular type were cleared by strontium 90, however, with chronic localized plaque type were poorly responded. The relapses of the cleared papular type were noticed between 13 to 24 days intervals, and it appeared that the larger doses did not influence significantly the clinical results. 2. Almost all of the chronic eczematous dermatoses including lichen simplex chronicus, nummular eczema, pustulosis Palmaris et plantaris, and chronic eczema of the finger, which were irradiated by beta rays following clearance with preliminary corticosteroid therapy, were recurred between 2 to 4 weeks intervals. However, larger doses resulted in prolonged recurrence intervals in a few patients. 3. No noticeable eariy hazards of irradiation were detected except for the mild hyperpigmentation on the irradiated skin.
Beta Particles ; Eczema ; Fingers ; Humans ; Hyperpigmentation ; Neurodermatitis ; Psoriasis ; Recurrence ; Skin ; Skin Diseases* ; Strontium*

We reported the case of Mr. M.H. Lee aged 46 years, who was first seen March. 4, 1972. The Chief complaint was pain on the left forehead and nausea for one day. Tension with the Schiotz tonometer was 45mmHg. The skin of left side of the forehead, inside of the eyebrow, left side of the radix nasi and nostril showed irregular papule formation in small circumscribed areas 2 days after admission. Acute iritis finding was occurred 6 days after the onset. The clinical course was one month. Sensitivity of the cornea was recovered and vision was improved to normal without posterior synechia or corneal ulcer.
Cornea ; Corneal Ulcer ; Eyebrows ; Forehead ; Glaucoma* ; Herpes Zoster Ophthalmicus* ; Herpes Zoster* ; Iritis ; Nausea ; Skin

No abstract available.
Adolescent* ; Humans

No abstract available.
Education* ; Running*

No abstract available.
Tuberculosis, Lymph Node*

Multiple myeloma is a primary malignant tumor of bone marrow characterized by proliferation of cells arising from primitive marrow reticulum that resemble plasma cells. This is one of the most common primary malignant neoplasm involving bone elements. Bone pain, soft tissue mass, low grade fever, anemia, neurologic symptom and renal insufficiency are the main clinical pictures. Authors present radiological and clinical findings of multiple myeloma in 10 cases of pathologically proved multiple myeloma. The results obtained are as follows; 1. In the age and sex distributions, all cases are over 45 years of age, and male to female is 7:3. 2. Clinical manifestations are bone pain, anemia, infection, weight loss, and bleeding. 3. Radiological findings are numerous punched out osteolytic lesions, generalized osteoporosis & osteolytic change, pathologic compression fractures, fracture only and osteoporosis, lytic and fractures. 4. Laboratory findings are monoclonal gammopathy in serum-electrophoresis, proteinuria, anemia, elevated uric acid in serum, Bence-Jones protein in urine and albumin/globulin ration inverse in serum protein.
Anemia ; Bone Marrow ; Female ; Fever ; Fractures, Compression ; Hemorrhage ; Humans ; Male ; Multiple Myeloma ; Neurologic Manifestations ; Osteoporosis ; Paraproteinemias ; Plasma Cells ; Proteinuria ; Renal Insufficiency ; Reticulum ; Sex Distribution ; Uric Acid ; Weight Loss

No abstract available.
Electrophoresis*

The study was conducted to compare the quality life (QOL), health perception and self efficacy of the ostomates by the fecal control type. The study sbjects included 128 ostomates in Pusan, Daegu, Daejon and Incheon branches of the Korean Ostomy Association. Data collection was performed for 27 day periods from September 10th to October 6th. 1988. The instruments used in this study were the OL scale developed by Bang (1991). the health perception scale developed by Ware and translated to Korean by Lee (1987), the self efficacy scale developed by Kim( 1995). The analysis of the data was done by the use of descriptive statistics. Chi-square test, ANCOVA and Pearson Correlation with the SAS program. The results of the study are summarized below. 1. Only age was a significant difference between the two groups(p=.014). 2. The ostomate-related characteristics which showed significant differences were the number of participations in the ostomate meetings each month(p=.001). the care manager(p=.017), the number of defecations(p=.001). problems with the colostomy(p=.003), the duration of the ostomates(p=.00l). These variables were controlled using the ANCOVA. 3. The first hypothesis. "There will be differences at the level of the QOL according to the fecal control type" was supported(F=7.87, p .0059). 4. The second hypothesis. "There will be differences at the level of health perception depending on the fecal control type" was supported (F =8.68, p = .0039). 5. The third hypothesis, "There will be differences at the level of self efficacy depending on the fecal control type" was supported(F=4.58. p=.0344). 6. There were significant positive correlation between the QOL and health perception(r= .8225. p=.0001), and self efficacy(r=.6356, p=000l). From the above results, it can be concluded that colostomy irrigation is a good method to improve the QOL, health perception and self-efficacy. Therefore, colostomy irrigation is an important method for rehabilitation nursing use in the care of ostomates.
Busan ; Colostomy ; Daegu ; Daejeon ; Data Collection ; Health Status ; Incheon ; Ostomy ; Quality of Life* ; Rehabilitation Nursing ; Self Efficacy

BACKGROUND: It is now well established that hypercholesterolemia is an important cause of coronary heart disease, and clinical intervention studies have demonstrated the therapeutic value of correcting hypercholesterolemia. One of lipoprotein, lipoprotein(a) [LP(a)] contains one(or two) molecule of apo(a) linked to apo B100 by a disulphied bridge, is associated with an increased risk of coronary heart disease. NIDDM patients have a two-to fourfold increased risk of coronary heart disease relative to nondiabetic subjects. This excess risk is explained only partially by increased levels of standard risk factors. This study was conducted to assess the relatioship between serum Lp(a) levels and coronary heart disease. Furthermore, whether the Lp(a) level was related with NIDDM or not. METHODS: Total 83 subjects undergoing coronary angiography were evaluated on clinical risk factors and lipid profies with Lp(a). Among them, 24 subjects had normal coronary artery, while the others revealed significant stenosis of coronary arteries more than 50%. RESULTS: The serum Lp(a) levels of the CHD group were significantly higher than control group(37.4 +/- 31.8mg/dl vs 22.6 +/- 12.9mg/dl). Other lipids profile were not significantly dfferent between two groups. Serum Lp(a) levels had no relations to fasting blood sugar level. Multivariate logistic regression analysis of lipid parameters revealed that cholesterol, LDL-cholesterol, and Lp(a) were best discriminator among risk factors for coronary heart disease. But in our study, the serum cholesterol and LDL-cholesterol levels were within normal range. CONCLUSION: This study suggested that Lp(a) level was a significant independent risk factor for coronary heart disease whether there was fasting hyperglycemia or not.
Blood Glucose ; Cholesterol ; Constriction, Pathologic ; Coronary Angiography ; Coronary Disease* ; Coronary Vessels ; Diabetes Mellitus, Type 2* ; Fasting ; Humans ; Hypercholesterolemia ; Hyperglycemia ; Clinical Trial ; Lipoprotein(a)* ; Lipoproteins ; Logistic Models ; Reference Values ; Risk Factors*